98 related articles for article (PubMed ID: 2675337)
1. [Changes in central hemodynamics and renal blood flow after correction of arterial hypertension with diltiazem].
Ivleva AIa; Gavrilova EN; Krasnobaeva GM; Shatkovskiĭ NP; Gaĭdamakina NE
Sov Med; 1989; (5):70-3. PubMed ID: 2675337
[No Abstract] [Full Text] [Related]
2. Effects of diltiazem hydrochloride on the reduction of blood pressure, and cardiac and renal functions in essential hypertensive patients with renal dysfunction.
Ohashi H; Ishiguro M; Yasue T; Kotoo Y; Kamakura M; Watanabe S; Sugishita N; Morita N
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):291-6. PubMed ID: 3623733
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of prolonged antihypertensive treatment with diltiazem.
Tramonti G; Donadio C; Silvestri L; Caputo M; Lucchetti A; Giordani R; Bianchi C
Kidney Int Suppl; 1996 Jun; 55():S78-80. PubMed ID: 8743517
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Slataper R; Vicknair N; Sadler R; Bakris GL
Arch Intern Med; 1993 Apr; 153(8):973-80. PubMed ID: 8386921
[TBL] [Abstract][Full Text] [Related]
5. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension].
Pshenitsin AI; Glotov MN; Mazur NA
Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of diltiazem in primary hypertension.
Sunderrajan S; Reams G; Bauer JH
Hypertension; 1986 Mar; 8(3):238-42. PubMed ID: 3949375
[TBL] [Abstract][Full Text] [Related]
7. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
Asberg A; Christensen H; Hartmann A; Berg KJ
Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
[TBL] [Abstract][Full Text] [Related]
8. Effect of clonidine therapy on renal hemodynamics in renal transplant hypertension.
Green S; Zawada ET; Muakkassa W; Johnson M; Mackenzie T; McClanahan M; Graybill A; Goldman M
Arch Intern Med; 1984 Jun; 144(6):1205-8. PubMed ID: 6375612
[TBL] [Abstract][Full Text] [Related]
9. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
Nievelstein HM; van Essen H; Hornsveld R; Struyker-Boudier HA; Smits JF
J Pharmacol Exp Ther; 1985 Dec; 235(3):778-82. PubMed ID: 4078731
[TBL] [Abstract][Full Text] [Related]
10. Renal plasma flow and glomerular filtration rate during antihypertensive therapy in essential hypertension.
Pedersen EB; Danielsen H; Eiskjaer H; Jespersen B; Sørensen SS; Thomsen OO
Dan Med Bull; 1987 Dec; 34 Suppl 1():7-8. PubMed ID: 3436171
[No Abstract] [Full Text] [Related]
11. Beta-blockers and the kidney.
Epstein M; Oster JR
Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
[No Abstract] [Full Text] [Related]
12. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
13. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
[TBL] [Abstract][Full Text] [Related]
14. [Prestarium treatment of essential hypertension].
Kakhnovskiĭ IM; Sivkov SI; Gavrilova EN; Belaia OL; Sivkov AS; Markova ZS; Markov IE; Gaĭdamakina NE
Klin Med (Mosk); 1998; 76(9):52-4. PubMed ID: 9821376
[TBL] [Abstract][Full Text] [Related]
15. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
Chaignon M; Barrou Z; Ayad M; Guédon J
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
[TBL] [Abstract][Full Text] [Related]
16. Nephroprotection by antihypertensive agents.
Schmieder RE
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
[TBL] [Abstract][Full Text] [Related]
17. [Ramipril in the treatment of hypertension. The pharmacodynamic validation of its efficacy in the therapy of initial cardiac and renal involvement].
Ivleva AIa; Moiseev VS; Antiia ID
Ter Arkh; 1993; 65(4):52-8. PubMed ID: 8059408
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
Strandgaard S; Elmgreen J; Christensen TE; Laursen SW
Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
[No Abstract] [Full Text] [Related]
19. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
Epstein M; Hollenberg NK
Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
[No Abstract] [Full Text] [Related]
20. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
